Laura Sánchez‐Muñoz

Clinical, biological, and molecular characteristics of clonal mast cell disorders presenting with systemic mast cell activation symptoms

Iván Álvarez‐Twöse, David González‐de‐Olano, Laura Sánchez‐Muñoz et al. · Journal of Allergy and Clinical Immunology · 2010 · 291 citations

Life Sciences, Cell Biology, Immunology +16

Prognosis in adult indolent systemic mastocytosis: A long-term study of the Spanish Network on Mastocytosis in a series of 145 patients

Luís Escribano, Iván Álvarez‐Twöse, Laura Sánchez‐Muñoz et al. · Journal of Allergy and Clinical Immunology · 2009 · 289 citations

Life Sciences, Internal Medicine, Pathology +8

Mortality comparison between the first and second/third waves among 3,795 critical COVID-19 patients with pneumonia admitted to the ICU: A multicentre retrospective cohort study

Raquel Carbonell, Silvia Urgelés, Alejandro Rodríguez et al. · The Lancet Regional Health - Europe · 2021 · 206 citations · Full text

Medicine, Clinical Sciences, Infectious Diseases +10

Validation of the REMA Score for Predicting Mast Cell Clonality and Systemic Mastocytosis in Patients with Systemic Mast Cell Activation Symptoms

David González‐de‐Olano, Laura Sánchez‐Muñoz, Almudena Matito et al. · International Archives of Allergy and Immunology · 2011 · 184 citations

Life Sciences, Immunology, Pathology +15

Increased serum baseline tryptase levels and extensive skin involvement are predictors for the severity of mast cell activation episodes in children with mastocytosis

Iván Álvarez‐Twöse, Sérgio Vañó-Galván, Laura Sánchez‐Muñoz et al. · Allergy · 2012 · 162 citations · Full text

Life Sciences, Immunology, Pediatrics +15